Nascent Biotech, Inc.
OTC: NBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sean Carrick
- Headquarters
- Vero Beach, United States
- IPO year
- 2009
- Market cap
- $86.1K
- Website
- https://www.nascentbiotech.com
Loading NBIO…
Loading profile data…Frequently asked questions about NBIO
What does Nascent Biotech, Inc. (NBIO) do?
Nascent Biotech, Inc., a clinical-stage biopharmaceutical firm, is committed to creating monoclonal antibody-based treatments for various forms of cancer. A primary focus is Pritumumab, a therapeutic currently in development to address aggressive brain malignancies such as glioblastoma and malignant astrocytoma. This drug also targets numerous e...
Where does NBIO trade?
Nascent Biotech, Inc. (NBIO) trades on the Other OTC.
What sector is NBIO in?
Nascent Biotech, Inc. (NBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nascent Biotech, Inc.?
Sean Carrick is the chief executive officer of Nascent Biotech, Inc. (NBIO).
Where is Nascent Biotech, Inc. headquartered?
Nascent Biotech, Inc. is headquartered in United States.
Does NBIO pay a dividend?
Nascent Biotech, Inc. (NBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NBIO go public?
Nascent Biotech, Inc. (NBIO) completed its initial public offering in 2009.